{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:07:45Z","timestamp":1787508465930,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81460209"],"award-info":[{"award-number":["81460209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijcrp.2025.200562","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:40:54Z","timestamp":1765500054000},"page":"200562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The sphingolipid metabolite sphingosine protects against hypertension by targeting metabolic-inflammatory crosstalk via the NLRP3 inflammasome"],"prefix":"10.1016","volume":"28","author":[{"given":"Wenjun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9200-062X","authenticated-orcid":false,"given":"Xingfang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10296","key":"10.1016\/j.ijcrp.2025.200562_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(21)00221-X","article-title":"Arterial hypertension","volume":"398","author":"Brouwers","year":"20217","journal-title":"Lancet"},{"issue":"10010","key":"10.1016\/j.ijcrp.2025.200562_bib2","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the global Burden of disease study 2013","volume":"386","author":"Forouzanfar","year":"201512","journal-title":"Lancet"},{"issue":"10440","key":"10.1016\/j.ijcrp.2025.200562_bib3","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Brauer","year":"20245","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2025.200562_bib4","unstructured":"\u4e2d\u56fd\u9ad8\u8840\u538b\u9632\u6cbb\u6307\u5357\u4fee\u8ba2\u59d4\u5458\u4f1a, \u9ad8\u8840\u538b\u8054\u76df(\u4e2d\u56fd), \u4e2d\u56fd\u533b\u7597\u4fdd\u5065\u56fd\u9645\u4ea4\u6d41\u4fc3\u8fdb\u4f1a\u9ad8\u8840\u538b\u75c5\u5b66\u5206\u4f1a, \u4e2d\u56fd\u8001\u5e74\u533b\u5b66\u5b66\u4f1a\u9ad8\u8840\u538b\u5206\u4f1a, \u4e2d\u56fd\u8001\u5e74\u4fdd\u5065\u534f\u4f1a\u9ad8\u8840\u538b\u5206\u4f1a, \u4e2d\u56fd\u5352\u4e2d\u5b66\u4f1a. \u4e2d\u56fd\u9ad8\u8840\u538b\u9632\u6cbb\u6307\u5357\uff082024,\u4fee\u8ba2\u7248\uff09. \u4e2d\u534e\u9ad8\u8840\u538b\u6742\u5fd7\uff08\u4e2d\u82f1\u6587\uff09. 2024,;32(7):603\u2013700."},{"issue":"6","key":"10.1016\/j.ijcrp.2025.200562_bib5","first-page":"399","article-title":"Report on cardiovascular health and diseases in China 2021: an updated summary","volume":"20","author":"Hu","year":"20236","journal-title":"J. Geriatric Cardiol."},{"issue":"4","key":"10.1016\/j.ijcrp.2025.200562_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/bph.13230","article-title":"Inflammasome activity is essential for one kidney\/deoxycorticosterone acetate\/salt-induced hypertension in mice","volume":"173","author":"Krishnan","year":"20162","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijcrp.2025.200562_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12872-024-04310-2","article-title":"Association and interaction analysis of NLRP3 gene polymorphisms with hypertension risk: a case-control study in China","volume":"24","author":"Xia","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"10.1016\/j.ijcrp.2025.200562_bib8","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10753-020-01215-y","article-title":"Nicardipine inhibits priming of the NLRP3 inflammasome via suppressing LPS-Induced TLR4 expression","volume":"43","author":"Chang","year":"20208","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.ijcrp.2025.200562_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41569-024-01062-6","article-title":"Reactive oxygen species in hypertension","volume":"22","author":"Camargo","year":"20251","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcrp.2025.200562_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.470","article-title":"NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension","volume":"8","author":"Sun","year":"2017","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ijcrp.2025.200562_bib11","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1159\/000486061","article-title":"NLRP3 gene deletion attenuates angiotensin II-Induced phenotypic transformation of vascular smooth muscle cells and vascular remodeling","volume":"44","author":"Ren","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"143","key":"10.1016\/j.ijcrp.2025.200562_bib12","article-title":"NLRP3 inflammasome contributes to endothelial dysfunction in angiotensin II-induced hypertension in mice","volume":"9","author":"Li","year":"2022","journal-title":"Microvasc. Res."},{"issue":"7","key":"10.1016\/j.ijcrp.2025.200562_bib13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/CIRCRESAHA.121.318052","article-title":"Hypertension: do inflammation and immunity hold the key to solving this epidemic?","volume":"128","author":"Madhur","year":"202142","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.ijcrp.2025.200562_bib14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.tem.2016.07.005","article-title":"Sphingolipid de novo biosynthesis: a rheostat of cardiovascular homeostasis","volume":"27","author":"Sasset","year":"2016","journal-title":"Trends Endocrinol. Metabol."},{"issue":"12","key":"10.1016\/j.ijcrp.2025.200562_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2156-12-44","article-title":"Genetics of the ceramide\/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension","volume":"5","author":"Fenger","year":"2011","journal-title":"BMC Genet."},{"key":"10.1016\/j.ijcrp.2025.200562_bib17","series-title":"Sphingolipid Metabolism and Metabolic Disease","first-page":"67","article-title":"Sphingosine 1-phosphate metabolism and signaling","author":"Hu","year":"2022"},{"issue":"13","key":"10.1016\/j.ijcrp.2025.200562_bib18","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1021\/jm4011687","article-title":"Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors","volume":"57","author":"Plano","year":"20147","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijcrp.2025.200562_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cvr\/cvw256","article-title":"Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension","volume":"113","author":"Meissner","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.ijcrp.2025.200562_bib20","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/HYPERTENSIONAHA.122.19862","article-title":"S1P (Sphingosine-1-Phosphate)-Induced vasodilation in human resistance arterioles during health and disease","volume":"79","author":"Katunaric","year":"2022","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.ijcrp.2025.200562_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10111706","article-title":"S1P\/S1P2 signaling axis regulates both NLRP3 upregulation and NLRP3 inflammasome activation in macrophages primed with lipopolysaccharide","volume":"10","author":"Lee","year":"2021","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.ijcrp.2025.200562_bib22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.201142079","article-title":"Sphingosine regulates the NLRP3-inflammasome and IL-1\u03b2 release from macrophages","volume":"42","author":"Luheshi","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.ijcrp.2025.200562_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1109\/TMI.2017.2749140","article-title":"Structured sparse principal components analysis with the TV-elastic net penalty","volume":"37","author":"De Pierrefeu","year":"2018","journal-title":"IEEE Trans. Med. Imag."},{"issue":"W1","key":"10.1016\/j.ijcrp.2025.200562_bib25","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ijcrp.2025.200562_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000000131","article-title":"Dietary fish oil improves endothelial function and lowers blood pressure via suppression of sphingolipid-mediated contractions in spontaneously hypertensive rats","volume":"32","author":"van den Elsen","year":"2014","journal-title":"J. Hypertens."},{"issue":"7","key":"10.1016\/j.ijcrp.2025.200562_bib32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","article-title":"Oxidative stress and hypertension","volume":"128","author":"Griendling","year":"2021","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.ijcrp.2025.200562_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","article-title":"NLRP3 inflammasome in endothelial dysfunction","volume":"11","author":"Bai","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.ijcrp.2025.200562_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/antiox12020281","article-title":"Oxidative stress, antioxidants and hypertension","volume":"12","author":"Amponsah-Offeh","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.ijcrp.2025.200562_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00395-017-0663-9","article-title":"Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases","volume":"113","author":"Liu","year":"2018","journal-title":"Basic Res. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcrp.2025.200562_bib36","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/jcp.31038","article-title":"Hyperuricemia promotes the progression of atherosclerosis by activating endothelial cell pyroptosis via the ROS\/NLRP3 pathway","volume":"238","author":"He","year":"2023","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.ijcrp.2025.200562_bib37","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"issue":"6577","key":"10.1016\/j.ijcrp.2025.200562_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.abg3067","article-title":"Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production","volume":"375","author":"Orecchioni","year":"2022","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ijcrp.2025.200562_bib39","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.33963\/KP.a2021.0108","article-title":"The effect of 1-year mean step count on the change in the atherosclerotic cardiovascular disease risk calculation in patients with high cardiovascular risk: a sub-study of the LIGHT randomized clinical trial","volume":"79","author":"Hay\u0131ro\u011flu","year":"2021","journal-title":"Kardiol. Pol."},{"issue":"9","key":"10.1016\/j.ijcrp.2025.200562_bib40","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1080\/00015385.2023.2223005","article-title":"The role of smart devices and mobile application on the change in peak VO2 in patients with high cardiovascular risk: a sub-study of the LIGHT randomised clinical trial","volume":"78","author":"Hay\u0131ro\u011flu","year":"2023","journal-title":"Acta Cardiol."},{"issue":"11","key":"10.1016\/j.ijcrp.2025.200562_bib41","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.33963\/KP.a2021.0112","article-title":"Effect of a mobile application and smart devices on heart rate variability in diabetic patients with high cardiovascular risk: a sub-study of the LIGHT randomized clinical trial","volume":"79","author":"Hay\u0131ro\u011flu","year":"2021","journal-title":"Kardiol. Pol."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525002004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525002004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:02:47Z","timestamp":1773918167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487525002004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"alternative-id":["S2772487525002004"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200562","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The sphingolipid metabolite sphingosine protects against hypertension by targeting metabolic-inflammatory crosstalk via the NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200562"}}